Orphan designation: Enzastaurin hydrochloride, Treatment of diffuse large B-cell lymphoma, 20/03/2007, Withdrawn | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 12 September 2023 - 15:22

Orphan designation: Enzastaurin hydrochloride, Treatment of diffuse large B-cell lymphoma, 20/03/2007, Withdrawn

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-07-442

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters